Axonics, Inc. (AXNX) Tops Q1 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Axonics, Inc. (AXNX) Tops Q1 EPS by 12c

Axonics® Reports First Quarter 2022 Financial Results

May 5, 2022 4:01 PM EDT

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the three months ended March 31, 2022.

We are pleased with this quarters revenue result considering the significant impact the Omicron surge had on elective procedures in January and February, said Raymond W. Cohen, chief executive officer of Axonics. Sacral neuromodulation procedure volumes recovered nicely in March and continued to trend favorably in April. Bulkamid® generated yet another quarter of... More